Are anti-dementia drugs useful in advanced dementia?

Phase 1

• Conditions: Advanced dementia; Therapeutic area: Diseases [C] - Nervous System Diseases [C10]

• Registration Number: EUCTR2017-000042-22-ES
• Lead Sponsor: GAP MALLORCA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-03-10
• Last Update Posted: 22 May 2017

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

- Patients with severe Alzheimer's disease, with or without a coexisting diagnosis of vascular dementia
- Score of =10 on the Standardized Mini-Mental State
- Previously treatred with ChI (with or without memantine) for at least 3 months
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 302

Exclusion Criteria

- Patients with another type of advanced dementia.
- Life expectancy less than 1 year

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified